Introduction
Recently we found (Endres et al., 1995) that the anaerobic vitamin B12-producing microorganism E. lim osum transforms 4(5)-aminoimidazole into 7-azabenzimidazolylcobamide and 5,6-dimethyl-7-azabenzimidazolylcobamide. Since these vitamin B12 analogs were only formed in microgram quan tities, it was desirable to prepare them at least in milligram amounts for further studies. 4(7)-Azabenzimidazole is commercially avail able. On addition of this base to cultures of P. sher m anii or E. limosum 4-azabenzimidazolylcobamide and 7-azabenzimidazolylcobamide were readily prepared (Endres et al., 1995) . By contrast 4(7)-aza-5,6-dimethylbenzimidazole is not a com mercial product. In the synthesis of this base de scribed in the literature (Dornow et al., 1958 ) the pyridine structure is formed first, followed by the imidazole structure.
Since Ramsden and his group (Lythgoe and Ramsden, 1994) showed that 5-unsubstituted 4-aminoimidazoles are well suited for reactions in Reprint requests to Prof. Renz. Fax: 0711-459-2283. position 5, we tried to synthesize 4(7)-aza-5,6-dimethylbenzimidazole from N-l-benzyl-4-aminoimidazole forming the pyridine ring as last step.
Here we report on this synthesis, and on the bio synthetic preparation of 4-aza-5,6-dimethylbenzimidazolylcobamide and 5,6-dimethyl-7-azabenzimidazolylcobamide by a Psherm anii-culture grown in the presence of 4(7)-aza-5,6-dimethylbenzimidazole. In addition we tested the growth activity of 4-azabenzimidazolylcobamide, 4-aza-5,6-dimethylbenzimidazolylcobamide, 7-azabenz imidazolylcobamide and 5,6-dimethyl-7-azabenzimidazolylcobamide with a vitamin B 12-depen dent E. co//-mutant.
Results and Discussion
We prepared 4(7)-aza-5,6-dimethylbenzimidazole (5) by a new synthetic method from N-l-benzyl-4-nitroimidazole (1) via N-l-benzyl-4-aminoimidazole (3) and N-l-benzyl-4-aza-5,6-dimethylbenzimidazole (4) (Fig. 1) . N-l-Benzyl-4-nitroimidazole was synthesized from 4(5)-nitroimidazole and benzyl chloride according to a variation (see experimental section) of a procedure described in the literature (Iradyan et al., 1978) . Theoretically the benzylation of 4(5)-nitroimidazole could lead 0939-5075/97/0500-0287 $ 06.00 © 1997 Verlag der Zeitschrift für Naturforschung. All rights reserved. to N-l-benzyl-4-nitroimidazole or to N-l-benzyl-5-nitroimidazole or to a mixture of both. However, N-l-benzyl-4-nitroimidazole prepared according to our procedure was exclusively the 4-nitro-compound. This was demonstrated by 'H N M R mea surements (NOE experiments, data not shown). 4(7)-Aza-5,6-dimethylbenzimidazole was trans formed by the aerotolerant anaerobe P. shermanii into a mixture of 4-aza-5,6-dimethylbenzimidazolylcobamide (7) and 5,6-dimethyl-7-azabenzimidazolylcobamide (9) which was separated by HPLC (Fig. 2) . According to the mass spectrum both corrinoids had the same molecular mass of 1356. The 4-position of the aza nitrogen in the base moiety of 4-aza-5,6-dimethylbenzimidazolylcobamide was determined by a 'H-NOE-spectrum of its dicyano form in 2H 20. Irradiation at the frequency of the l '-H-proton of the ribose (6.17 ppm) evoked the signals of the protons at C-2 (8.31 ppm) and C-7 (7.66 ppm) of the base.
Finally the isolated vitamin B 12-analogs were tested for their vitamin B 12 activity with the vita min B12-requiring E. co//-mutant DSM 4261. As shown in Table I the two dimethylazabenzimidazolylcobamides 7 and 9 are almost as active as vita min B12 whereas the azadimethylbenzimidazolylcobamides 6 and 8 are much less active. The values of single determinations are scattered over a rela tively wide range. This is due to the high sensitivity of the test (Skeggs, 1966) . It would be interesting to test now the influence of these corrinoids on eukaryotic cells in culture, and their Co-5'-desoxyadenosyl derivatives (coenzym form) on vitamin B 12-dependent reactions.
Materials and Methods
Solvent for TLC: A: chloroform/ethanol/acetic acid = 85/15/2 (by vol.). Solvent for descending pa per chromatography: B: butan-2-ol/water/acetic acid/1% aqueous HCN = 70/28/1/1 (by vol.).
TLC aluminium sheets silica gel 60 F254 (Merck) were used for analytical purposes. Semiprepara tive purification of N-l-benzyl-4-aza-5,6-dimethylbenzimidazole and 4(7)-aza-5,6-dimethylbenzimi- dazole was carried out on pre-coated TLC plates silica gel 60 F254 20 x 20 cm, 2 mm (Merck). N -lBenzyl-4-nitroimidazole, N-l-benzyl-4-aza-5,6-dimethylbenzimidazole and 4(7)-aza-5,6-dimethylbenzimidazole were detected on TLC under ultra violet light of 254 nm.
The concentration of corrinoids was measured as described before (Endres et al., 1995) . 'H NMR spectra were recorded as published previously (Endres et al., 1995) . Molecular masses of corri noids were determined with methanolic solutions by electrospray mass spectroscopy in a Finnigan TSQ 700 spectrometer.
N -l-Benzyl-4-nitroim idazole
2.26 g (20 mmol) 4-nitroimidazole was sus pended in 60 ml triethylamine, heated under re flux and magnetic stirring. 5 ml (43.5 mmol) ben zyl chloride was added dropwise within 1 -2 h. Heating was continued for another 4 h. The solvent was decanted from the honey-colored pre cipitate and discarded. The product was dissolved in 30 ml ethanol, diluted with 70 ml water, brought to boiling in the presence of decolorizing carbon and filtered. On cooling white to lightly yellow crystals separated. Yield 3.45 g (17 mmol, 85% ). Mp. 7 5 -7 8 °C (after recrystallization, 76 °C ac cording to Cosar et al., 1966) . R f in solvent A: 4-nitroimidazole 0.47; N-l-benzyl-4-nitroimidazole 0.88.
N -l-B enzyl-4-aza-5,6-dim ethylben zim idazole
2.03 g (10 mmol) N-l-benzyl-4-nitroimidazole, dissolved in 50 ml ethanol, was hydrogenated with 1 g Pd/BaS04 (5% Pd, Sigma, Deisenhofen, Ger many) for 6 h at 8 atm hydrogen and 40 °C. The catalyst was removed by centrifugation, the solvent evaporated, the residue dissolved in 30 ml ethanol/acetic acid (5 : 1, by vol.), 1.42 g (11 mmol) l-dimethylamino-2-methylbutan-3-one (Becker et al., 1996) added, and heated under reflux for 5 h. The solvent was evaporated, the residue dissolved in 4 m HC1, extracted three times with methylene chloride, and the organic phase discarded. The aqueous phase was adjusted to pH 1 1 -1 2 with 4 m NaOH, and the N-l-benzyl-4-aza-5,6-dimethylbenzimidazole extracted with three portions of methylene chloride. The solvent was evaporated, and the product distilled at reduced pressure to the cooling device of a sublimation apparatus at 180-190 °C. Yield 970 mg (4.09 mmol, 41% ).
The crude product was recrystallized from water/ethanol = 95/5 in the presence of charcoal. Yield 130 mg, mp. 160-163 °C. R f in solvent A: 0.76. A better yield of pure product was obtained by preparative TLC (50 mg, dissolved in ethanol, per plate) with solvent A. The main band was eluted from the silicagel with ethanol/conc. aque ous ammonia = 100/5 (vol/vol), the solvent evapo rated, and N-l-benzyl-4-aza-5,6-dimethylbenzimidazole extracted from an aqueous alkaline solution as described above.
MS ( 
4(7)-A za-5,6-dim ethylbenzim idazole
500 mg (2.1 mmol) N-l-benzyl-4-aza-5.6-dimethylbenzimidazole was dissolved in 50 ml etha nol, 600 mg Pd/C (10% Pd) added, and the mix ture stirred under 15 atm hydrogen at 120 °C for 72 h. The catalyst was centrifuged off, the solvent evaporated, and the residue dissolved in 5 ml etha nol. The solution was applied as a band onto 5 TLC-silica gel F 254 plates (2 mm) and developed with solvent A. Thus 4-aza-5,6-dimethylbenzimidazole was separated from small amounts of faster moving N-l-benzyl-4-aza-5,6-dimethylbenzimidazole. R f of N-l-benzyl-4-aza-5,6-dimethylbenzimidazole in solvent A: 0.76, of 4-aza-5,6-dimethylbenzimidazole 0.51. 4-Aza-5,6-dimethylbenzimidazole was eluted from the silica gel with ethanol/ conc. aqueous ammonia = 100/5. On evaporation the acetate of 4-aza-5,6-dimethylbenzimidazole was obtained, due to the presence of acetic acid in solvent A. Yield 247 mg (1,68 mmol, 80% ).
In order to obtain the free base of 4-aza-5,6-dimethylbenzimidazole the acetate was dissolved in 1 m HC1, and extracted three times with methy lene chloride. The organic phase was discarded, the aqueous phase adjusted to pH 8.0 with 1 m NaOH, and extracted three times with methylene chloride. The solvent was evaporated and the resi due dried in vacuo. Mp. 2 2 7 -2 3 1 °C (after subli mation in vacuo; 220 °C according to Dornow et al., 1958) .
MS ( Biosynthetic preparation o f 4-aza-5,6-dim ethylbenzim id azoly lcobam id e and 5,6-dim ethyl-7-azabenzim (Renz. 1971) . 90 mg of 4(7)-aza-5,6-dimethylbenzimidazole (free base or acetate), dissolved in 3 ml 70% aqueous ethanol, was added to a 3-1 culture 48 h after inoculation, and the culture grown for another 5 d. 143 g wet cells were obtained. The corrinoids were isolated from the bacteria as their monocyano derivatives as described (Renz et al., 1993) . R B12-values (de scending paper chromatography with solvent B. Schleicher & Schuell-paper No. 3469): 4-aza-5,6-dimethylbenzimidazolylcobamide 0.99; 5,6-dimethyl-7-azabenzimidazolylcobamide 0.73. Final purification of these corrinoids was achieved by HPLC on a LiChrospher 2 5 0 -4 RP-18 (5 mm) col umn (Merck) with 0.1% aqueous acetic acid/meth anol (75/25, v/v) as solvent (flow rate 1 ml/min, de tection at 361 nm) (Endres et al., 1995) . Retention time (min): 4-aza-5,6-dimethylbenzimidazolylcobamide 15.1; 5,6-dimethyl-7-azabenzimidazolylcobamide 10.0; vitamin B12 (cyanocobalamin) 13.3. Yields: 4-aza-5,6-dimethylbenzimidazolylcobamide 5.14 mg; 5,6-dimethyl-7-azabenzimidazolyl-cobamide 2.15 mg. The molecular mass of both corri noids was 1356, determined from the M + Na (1379) and M + K (1395) peaks.
Growth tests with Escherichia coli DSM 4261 on vitamin B12 activity
The vitamin B12-requiring E. coli mutant was obtained from DSM -Deutsche Sammlung von Mikroorganismen (Braunschweig, Germany). The tests were carried out as described (Mücke, 1957; Endres, 1996) in 4 ml of the minimal medium pub lished for Escherichia coli B by Süßmuth (Süßmuth et al., 1987) . The growth activity was tested with the following concentrations of the vi tamin B12 analogs (pmol/4 ml): 0; 0.005; 0.01; 0.02; 0.04; 0.08; 0.1;0.2; 0.4;0.8; 2. Triplicate assays were performed for each concentration. Concomittantly triplicate assays were carried out with vitamin B12 at the same concentrations. The test tubes were in cubated for 15 h at 30 °C with shaking (80 min-1). The absorbance was measured at 578 nm using the assay without corrinoid as reference.
The logarithm of the concentration (abscissa) was drawn in a diagram versus the absorbance (or dinate). The per cent activity was calculated from the curve of the vitamin B12 analog in comparison with the curve of vitamin B12 (Endres, 1996) .
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